Kulawik

Kutzsche J, Schemmert S, Bujnicki T, Zafiu C, Halbgebauer S, Kraemer-Schulien V, Pils M, Blömeke L, Post J, Kulawik A, Jürgens D, Rossberg WM, Hümpel M, Bannach O, Otto M, Araujo JA, Willuweit A, Willbold D.
Oral treatment with the all-d-peptide RD2 enhances cognition in aged beagle dogs - A model of sporadic Alzheimer's disease
Heliyon 29;9(8):e18443, (2023)
https://pubmed.ncbi.nlm.nih.gov/37609390/
Kulawik A,Heise H,Zafiu C,Willbold D,Bannach O.
Advancements of the sFIDA method for oligomer-based diagnostics of neurodegenerative diseases
FEBS Letters , (2018)
http://onlinelibrary.wiley.com/doi/10.1002/1873-3468.12983/abstract
CLICK
Herrmann Y, Bujnicki T, Zafiu C, Kulawik A, Kühbach K, Peters L, Fabig J, Willbold J, Bannach O, Willbold D.
Nanoparticle standards for immuno-based quantitation of α-synuclein oligomers in diagnostics of Parkinson's disease and other synucleinopathies.
Clin Chim Acta 466, 152–159 (2017)
http://dx.doi.org/10.1016/j.cca.2017.01.010
http://www.sciencedirect.com/science/article/pii/S0009898117300104
Herrmann Y, Kulawik A, Kühbach K, Hülsemann M, Peters L, Bujnicki T, Kravchenko K, Linnartz C, Willbold J, Zafiu C, Bannach O, Willbold D.
sFIDA automation yields sub-femtomolar limit of detection for Aβ aggregates in body liquids.
Clinical Biochem. 50(4-5), 244-247 (2017)
http://dx.doi.org/10.1016/j.clinbiochem.2016.11.001
http://www.sciencedirect.com/science/article/pii/S0009912016305008
Kravchenko K, Kulawik A, Hülsemann M, Kühbach K, Zafiu C, Herrmann Y, Linnartz C, Peters L, Bujnicki T, Willbold J, Bannach O, Willbold D.
Analysis of anticoagulants for blood-based quantitation of amyloid β oligomers in the sFIDA assay.
Biol. Chem. 398(4), 465-475 (2017)
https://dx.doi.org/10.1515/hsz-2016-0153
https://www.degruyter.com/view/j/bchm.ahead-of-print/hsz-2016-0153/hsz-2016-0153.xml
Kühbach K, Hülsemann M, Herrmann Y, Kravchenko K, Kulawik A, Linnartz C, Peters L, Wang K, Willbold J, Willbold D, Bannach O.
Application of an amyloid beta oligomer standard in the sFIDA assay.
In: Biomarkers of Alzheimer's Disease: The Present and the Future. Eds. Sylvain Lehmann, Charlotte Elisabeth Teunissen. , 39-44 (2017)
ISBN 9782889450411
Hülsemann M, Zafiu C, Kühbach K, Lühmann N, Herrmann Y, Peters L, Linnartz C, Willbold J, Kravchenko K, Kulawik A, Willbold S, Bannach O, Willbold D.
Biofunctionalized Silica Nanoparticles: Standards in Amyloid-β Oligomer-Based Diagnosis of Alzheimer's Disease.
J. Alzheimers Dis. 54, 79-88 (2016)
https://dx.doi.org/10.3233/JAD-160253
http://content.iospress.com/articles/journal-of-alzheimers-disease/jad160253
Kühbach K, Hülsemann M, Herrmann Y, Kravchenko K, Kulawik A, Linnartz C, Peters L, Wang K, Willbold J, Willbold D, Bannach O.
Application of an Amyloid Beta Oligomer Standard in the sFIDA Assay
Front. Neurosci. 10:8, (2016)
http://dx.doi.org/10.3389/fnins.2016.00008
http://journal.frontiersin.org/article/10.3389/fnins.2016.00008
Wördehoff MM, Bannach O, Shaykhalishahi H, Kulawik A, Schiefer S, Willbold D, Hoyer W, Birkmann E
Single fibril growth kinetics of alpha-synuclein.
J. Mol. Biol. 427, 1428-1435 (2015)
http://dx.doi.org/10.1016/j.jmb.2015.01.020
http://journal.frontiersin.org/article/10.3389/fnins.2016.00008/abstract

Verantwortlichkeit: